Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAVE
3476
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.78M | ﹤0.01% |
+100,000
| New | +$1.43M |
|
|
ERUS
3477
DELISTED
iShares MSCI Russia ETF
ERUS
| $1.78M | ﹤0.01% |
+53,182
| New | +$1.73M |
|
3478
Colliers International
CIGI
$5.19B
| $1.78M | ﹤0.01% |
31,033
-67,087
| -68% | -$3.59M |
|
|
RCM
3479
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.78M | ﹤0.01% |
159,467
-83,386
| -34% | -$858K |
|
3480
Angi Inc
ANGI
$196M
| $1.78M | ﹤0.01% |
14,623
+1,555
| +12% | +$142K |
|
3481
PUT
HCA Healthcare
HCA
$89.5B
| $1.78M | ﹤0.01% |
18,300
| – | – |
|
|
ADAM
3482
CALL
Adamas Trust
ADAM
$883M
| $1.77M | ﹤0.01% |
+170,000
| New | +$1.49M |
|
|
GDP
3483
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.77M | ﹤0.01% |
246,435
-116,381
| -32% | -$821K |
|
|
AKRO
3484
DELISTED
Akero Therapeutics
AKRO
| $1.76M | ﹤0.01% |
70,771
+16,108
| +29% | +$368K |
|
3485
Camden National
CAC
$976M
| $1.76M | ﹤0.01% |
51,049
+20,843
| +69% | +$659K |
|
3486
Andersons Inc
ANDE
$2.22B
| $1.76M | ﹤0.01% |
127,947
-47,464
| -27% | -$689K |
|
|
BFS
3487
Saul Centers
BFS
$834M
| $1.76M | ﹤0.01% |
54,546
+16,762
| +44% | +$534K |
|
3488
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.83B
| $1.76M | ﹤0.01% |
+41,304
| New | +$1.66M |
|
3489
CALL
VanEck Semiconductor ETF
SMH
$73.2B
| $1.76M | ﹤0.01% |
23,000
-267,200
| -92% | -$18.4M |
|
|
LGTY
3490
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.75M | ﹤0.01% |
111,346
-11,822
| -10% | -$199K |
|
3491
Ocular Therapeutix
OCUL
$2.02B
| $1.75M | ﹤0.01% |
210,618
+125,482
| +147% | +$832K |
|
|
MYOV
3492
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.75M | ﹤0.01% |
84,938
+19,157
| +29% | +$261K |
|
3493
Frontline
FRO
$8.85B
| $1.75M | ﹤0.01% |
250,437
-98,622
| -28% | -$837K |
|
3494
ADMA Biologics
ADMA
$2.22B
| $1.75M | ﹤0.01% |
595,525
+101,351
| +21% | +$291K |
|
3495
Seres Therapeutics
MCRB
$48.4M
| $1.74M | ﹤0.01% |
18,320
+9,991
| +120% | +$877K |
|
|
PFC
3496
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.74M | ﹤0.01% |
98,677
+21,886
| +29% | +$354K |
|
3497
Daktronics
DAKT
$1.04B
| $1.74M | ﹤0.01% |
400,717
-89,072
| -18% | -$394K |
|
3498
PUT
AstraZeneca
AZN
$250B
| $1.74M | ﹤0.01% |
+16,450
| New | +$1.7M |
|
|
TGI
3499
DELISTED
Triumph Group
TGI
| $1.74M | ﹤0.01% |
192,656
-384,166
| -67% | -$2.84M |
|
3500
First Majestic Silver
AG
$9.07B
| $1.73M | ﹤0.01% |
173,996
-55,929
| -24% | -$474K |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.